3-D tissue models provide a means for repetitive, systematic and quantitative investigation of drugs, serving as platforms for screening of drugs as well as pharmacodynamic and pharmacokinetic analysis of drugs.
2nd Annual Engineering Functional 3-D Tissue Models 2013 covers topics such as:
- Use of 3-D Porous Natural Polymer Scaffolds for in vitro Tumor Microenvironment Models
- Emerging Technologies for Assembly of Microscale Hydrogels
- 3-D Intestinal Tissue Models
- Carbon-Nanotube-Embedded Hydrogel Sheets for Engineering Cardiac Constructs and Bioactuators
- From iPSC to 3-D Skin Equivalents: Dynamic Platforms to Study Human Disease
- Tissue Models of Disease and their Potential for High-Throughput Screening
- AlgiMatrix™-Based 3-D Cell Culture System as an in vitro Tumor Model for Anticancer Studies
- Next-Generation Bioengineered 3-D Human Tissue-Equivalent Platform System to Validate High-Volume Vaccine Production
- Drug Uptake and Diffusion in 3-D Multicellular Microtissues
- Inhibition of KRAS-Driven Tumorigenicity by Interruption of an Autocrine Cytokine Circuit
- Customized 3-D Cell Cultures and Assays Showcase
2nd Annual Engineering Functional 3-D Tissue Models 2013 brings together engineers, biologists, pharmacologists.
